Gabelli Funds’s Centessa Pharmaceuticals CNTA Stock Holding History

Gabelli Funds’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,600	Closed	-$699K	–	1297
2026 Q1	$699K	Buy	+17,600	New	+$450K	﹤0.01%	982

Gabelli Funds's CNTA Position: Q2 2026 in Review

Gabelli Funds sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 17,600 shares — an estimated $699K sold.

Gabelli Funds first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $699K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Gabelli Funds reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Gabelli Funds sold 17,600 Centessa Pharmaceuticals shares in Q2 2026, an estimated $699K.
Gabelli Funds first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Gabelli Funds's Centessa Pharmaceuticals position peaked at $699K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.